Comparative Study to Evaluate the Efficacy and Safety of Telithromycin Given Once Daily Versus Cefuroxime Axetil Given Twice Daily in Children With Middle Ear Infections

• Status: Terminated
• Trial end date: 2006-06-01

Summary

The clinical activity of telithromycin vs. cefuroxime in children with acute infections of the middle ear, ages 6 months to 59 months old will be studied.

• Phase: Phase 3

Details

• Lead Sponsor: Sanofi
• Treatments: Cefuroxime; Cefuroxime axetil; Telithromycin